Senate approves $275M to FDA, $400M to NIH

  
FDA, NIH nets Senate approval of increased funding. Source: Merchant Funding 
The FDA and National Institutes of Health (NIH) received funding increases in the FY 2008 Supplemental Appropriations bill that the Senate passed May 23.

In its $400 million appropriation to NIH, the Senate bill recognizes the need for increased appropriations for the NIH to fund about 700 research grants. The Senate also issued $275 million for the FDA, $437 million for the construction of polytrauma centers administered by the Department of Veterans Affairs and $350 million for hospitals in Louisiana and Mississippi as part of relief from Hurricane Katrina.

Of the $275 million for the FDA, $48 million will go to the Center for Drug Evaluation and Research and $23 million to the Center for Biologics Evaluation and Research. The funding will provide the FDA with the resources to keep pace with evolving biomedical science and make regulatory decisions in a timely and efficient manner, according to the agency.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.